|
Market Closed -
Nasdaq
01:00:00 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 234.76 USD | +3.27% |
|
+8.70% | +38.09% |
| 11-03 | RBC Raises Price Target on Jazz Pharmaceuticals to $305 From $296, Keeps Outperform Rating | MT |
| 11-03 | Jazz Pharmaceuticals plc, Q3 2026 Earnings Call, Nov 02, 2026 |
| Market Cap | 15.07B 13.52B 12.35B 11.28B 21.24B 1,417B 21.91B 149B 59.37B 756B 56.56B 55.35B 2,386B | P/E 2026 * |
67.4x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 17.82B 15.98B 14.61B 13.33B 25.12B 1,675B 25.92B 176B 70.21B 894B 66.89B 65.46B 2,822B | EV / Sales 2026 * |
3.71x | EV / Sales 2027 * | 3.18x |
| Free-Float |
96.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JAZZ | Delayed | |
CBOE
| JAZZ | Real-time | |
|
Tradegate
| J7Z | Real-time | |
|
Deutsche Boerse AG
| J7Z | Delayed | |
|
Boerse Muenchen
| J7Z | Real-time | |
|
Börse Stuttgart
| J7Z | Delayed | |
|
Berne S.E.
| J7Z | End-of-day quote | |
|
Borsa Italiana
| 1JAZZ | End-of-day quote | |
|
Xetra
| J7Z | Delayed |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | +3.27% | ||
| 1 week | +8.70% | ||
| Current month | +8.70% | ||
| 1 month | +1.54% | ||
| 3 months | -8.50% | ||
| 6 months | +3.44% | ||
| Current year | +38.09% |
| 1 week | 213.81 |  | 237.76 |
| 1 month | 202.3 | | 237.76 |
| Current year | 156.95 | | 266.38 |
| 1 year | 132.1 | | 266.38 |
| 3 years | 95.49 | | 266.38 |
| 5 years | 95.49 | | 266.38 |
| 10 years | 86.88 | | 266.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 11/08/2025 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 01/03/2024 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 01/03/2003 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 18/01/2012 |
Rick Winningham
BRD | Director/Board Member | 66 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/10/26 | Sell | Chief Executive Officer | -2,000 | 0.0031% | ||
| 01/10/26 | Sell | Founder | -6,000 | 0.0092% | ||
| 10/09/26 | Sell | General Counsel | -1,200 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.27% | +8.70% | +78.99% | +75.63% | 15.07B | |
| -0.79% | -4.48% | +46.48% | +125.69% | 1,206B | |
| +1.43% | +1.11% | +48.05% | +83.05% | 665B | |
| +1.07% | -1.21% | +32.92% | +104.92% | 515B | |
| -0.36% | -3.25% | +45.42% | +65.10% | 381B | |
| -0.14% | -1.87% | +70.06% | +41.09% | 362B | |
| -0.78% | -0.52% | +30.47% | +58.09% | 307B | |
| -0.80% | -0.21% | +7.98% | +36.17% | 289B | |
| +0.03% | -1.20% | +43.79% | +69.83% | 249B | |
| -0.41% | -2.22% | +40.43% | +107.03% | 207B | |
| Average | +0.25% | -0.52% | +44.46% | +76.66% | 419.48B | |
| Weighted average by Cap. | -0.03% | -1.92% | +42.84% | +88.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.8B 4.31B 3.94B 3.6B 6.77B 452B 6.99B 47.47B 18.93B 241B 18.03B 17.65B 761B | 5.05B 4.53B 4.14B 3.78B 7.12B 475B 7.34B 49.9B 19.9B 253B 18.96B 18.55B 800B |
| Net income | 274M 246M 225M 205M 386M 25.75B 398M 2.71B 1.08B 13.74B 1.03B 1.01B 43.38B | 1.12B 1B 915M 835M 1.57B 105B 1.62B 11.03B 4.4B 55.99B 4.19B 4.1B 177B |
| Net Debt | 2.75B 2.47B 2.26B 2.06B 3.88B 259B 4B 27.19B 10.84B 138B 10.33B 10.11B 436B | 975M 874M 799M 730M 1.37B 91.65B 1.42B 9.63B 3.84B 48.9B 3.66B 3.58B 154B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | $234.76 | +3.27% | 887,563 |
| 05/11/26 | $227.32 | -3.13% | 670,559 |
| 04/11/26 | $234.66 | +2.14% | 899,091 |
| 03/11/26 | $229.74 | +7.13% | 1,680,858 |
| 02/11/26 | $214.44 | -0.71% | 1,043,962 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
